International Agency for Research on Cancer (IARC). World Cancer Data [Internet]. Available from: https://gco.iarc.fr/today/en/dataviz/pie?mode=population&group_populations=0&cancers=11&types=1. Accessed 23 Oct 2024.

Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, et al. Thermal ablation compared to partial hepatectomy for recurrent colorectal liver metastases: an Amsterdam Colorectal Liver Met Registry (AmCORE) based study. Cancers (Basel). 2021;13(11):2769. https://doi.org/10.3390/cancers13112769.

Article  PubMed  Google Scholar 

Cucchetti A, Piscaglia F, Cescon M, Colecchia A, Ercolani G, Bolondi L, Pinna AD. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 2013;59(2):300–7. https://doi.org/10.1016/j.jhep.2013.04.009.

Article  PubMed  Google Scholar 

Jiang C, Feng Q, Zhang Z, Qiang Z, Du A, Xu L, Li J. Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. World J Surg Oncol. 2024;22(1):188. https://doi.org/10.1186/s12957-024-03473-8.

Article  PubMed  PubMed Central  Google Scholar 

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. https://doi.org/10.1016/j.jhep.2018.03.019. Erratum in: J Hepatol. 2019;70(4):817. https://doi.org/10.1016/j.jhep.2019.01.020

Vogel A, Martinelli E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org; ESMO Guidelines Committee. Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines. Ann Oncol. 2021;32(6):801–805. https://doi.org/10.1016/j.annonc.2021.02.014.

van der Lei S, Puijk RS, Dijkstra M, et al. Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial. Lancet Oncol. 2025;26:187–99.

Article  PubMed  Google Scholar 

Putzer D, Schullian P, Bale R. Locoregional ablative treatment of melanoma metastases. Int J Hyperthermia. 2019;36(2):59–63. https://doi.org/10.1080/02656736.2019.1647353.

Article  PubMed  Google Scholar 

Schullian P, Johnston E, Laimer G, Putzer D, Eberle G, Scharll Y, et al. Stereotactic radiofrequency ablation of breast cancer liver metastases: short- and long-term results with predicting factors for survival. Cardiovasc Intervent Radiol. 2021;44:1184–93. https://doi.org/10.1007/s00270-021-02820-6.

Article  PubMed  PubMed Central  Google Scholar 

Vogl TJ, Jaraysa Y, Martin SS, Gruber-Rouh T, Savage RH, Nour-Eldin NA, Mehmedovic A. A prospective randomized trial comparing microwave and radiofrequency ablation for the treatment of liver metastases using a dual ablation system—the Mira study. Eur J Radiol Open. 2022;9:100399. https://doi.org/10.1016/j.ejro.2022.100399.

Article  PubMed  PubMed Central  Google Scholar 

Meloni MF, Andreano A, Laeseke PF, Livraghi T, Sironi S, Lee FT Jr. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation—intermediate and long-term survival rates. Radiology. 2009;253(3):861–9. https://doi.org/10.1148/radiol.2533081968.

Article  PubMed  Google Scholar 

Verhagen CAM, van der Velden AL, Bale R, Bozzi E, Crocetti L, Denys A, van Erp GCM, Gholamiankhah F, Greco G, Hendriks P, Knapen RRMM, Kobeiter H, Lanocita R, Meijerink MR, Orsi F, Phillips A, Rahmani H, Smits MLJ, van Strijen MJL, van Dam RM, van der Leij C, Burgmans MC. The paradox of modern technology in standardizing thermal liver ablation: Fostering uniformity or diversity? Cardiovasc Intervent Radiol. 2024. https://doi.org/10.1007/s00270-024-03846-2.

Article  PubMed  PubMed Central  Google Scholar 

Solbiati LA. High-level standardization of ablative procedures: the way to go. Cardiovasc Intervent Radiol. 2023;46(12):1755–7. https://doi.org/10.1007/s00270-023-03596-7.

Article  PubMed  Google Scholar 

Oosterveer TTM, van Erp GCM, Hendriks P, Broersen A, Overduin CG, van Rijswijk CSP, van Erkel AR, van der Meer RW, Tushuizen ME, Moelker A, Meijerink MR, van Delden OM, de Jong KP, van der Leij C, Smits MLJ, Urlings TAJ, Braak JPBM, Meershoek-Klein Kranenbarg E, van Duijn-de VB, Zeijdner E, Goeman JJ, Fütterer JJ, Coenraad MJ, Dijkstra J, Burgmans MC. Study protocol PROMETHEUS: prospective multicenter study to evaluate the correlation between safety margin and local recurrence after thermal ablation using image co-registration in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2022;45(5):606–12. https://doi.org/10.1007/s00270-022-03075-5.

Article  PubMed  PubMed Central  Google Scholar 

Laimer G, Verdonschot KHM, Kopf L, van der Lei S, Scharll Y, Hannink G, Jenniskens SFM, Meijerink MR, Bale R, Overduin CG. Multicenter and inter-software evaluation of ablative margins after thermal ablation of colorectal liver metastases. Eur Radiol. 2024. https://doi.org/10.1007/s00330-024-10956-5.

Article  PubMed  PubMed Central  Google Scholar 

Hendriks P, van Dijk KM, Boekestijn B, Broersen A, van Duijn-de Vreugd JJ, Coenraad MJ, Tushuizen ME, van Erkel AR, van der Meer RW, van Rijswijk CS, Dijkstra J, de Geus-Oei LF, Burgmans MC. Intraprocedural assessment of ablation margins using computed tomography co-registration in hepatocellular carcinoma treatment with percutaneous ablation: IAMCOMPLETE study. Diagn Interv Imaging. 2024;105(2):57–64. https://doi.org/10.1016/j.diii.2023.07.002.

Article  PubMed  Google Scholar 

Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–6. https://doi.org/10.1007/s00270-017-1703-4.

Article  CAS  PubMed  Google Scholar 

da Silva Etges APB, Cruz LN, Notti RK, et al. An 8-step framework for implementing time-driven activity-based costing in healthcare studies. Eur J Health Econ. 2019;20(8):1133–45. https://doi.org/10.1007/s10198-019-01085-8.

Article  PubMed  Google Scholar 

Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, Choi BI, de Baère T, Dodd GD 3rd, Dupuy DE, Gervais DA, Gianfelice D, Gillams AR, Lee FT Jr, Leen E, Lencioni R, Littrup PJ, Livraghi T, Lu DS, McGahan JP, Meloni MF, Nikolic B, Pereira PL, Liang P, Rhim H, Rose SC, Salem R, Sofocleous CT, Solomon SB, Soulen MC, Tanaka M, Vogl TJ, Wood BJ, Goldberg SN; International Working Group on Image-guided Tumour Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology,; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Image-guided tumour ablation: standardization of terminology and reporting criteria—a 10-year update. Radiology. 2014;273(1):241–60. https://doi.org/10.1148/radiol.14132958.

Puijk RS, Ahmed M, Adam A, Arai Y, Arellano R, de Baère T, Bale R, Bellera C, Binkert CA, Brace CL, Breen DJ, Brountzos E, Callstrom MR, Carrafiello G, Chapiro J, de Cobelli F, Coupé VMH, Crocetti L, Denys A, Dupuy DE, Erinjeri JP, Filippiadis D, Gangi A, Gervais DA, Gillams AR, Greene T, Guiu B, Helmberger T, Iezzi R, Kang TW, Kelekis A, Kim HS, Kröncke T, Kwan S, Lee MW, Lee FT, Lee EW Jr, Liang P, Lissenberg-Witte BI, Lu DS, Madoff DC, Mauri G, Meloni MF, Morgan R, Nadolski G, Narayanan G, Newton I, Nikolic B, Orsi F, Pereira PL, Pua U, Rhim H, Ricke J, Rilling W, Salem R, Scheffer HJ, Sofocleous CT, Solbiati LA, Solomon SB, Soulen MC, Sze D, Uberoi R, Vogl TJ, Wang DS, Wood BJ, Goldberg SN, Meijerink MR. Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301(3):533–40. https://doi.org/10.1148/radiol.2021203715.

Article  PubMed  Google Scholar 

Odisio BC, Albuquerque J, Lin YM, Anderson BM, O'Connor CS, Rigaud B, Briones-Dimayuga M, Jones AK, Fellman BM, Huang SY, Kuban J, Metwalli ZA, Sheth R, Habibollahi P, Patel M, Shah KY, Cox VL, Kang HC, Morris VK, Kopetz S, Javle MM, Kaseb A, Tzeng CW, Cao HT, Newhook T, Chun YS, Vauthey JN, Gupta S, Paolucci I, Brock KK. Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial. Lancet Gastroenterol Hepatol. 2025:S2468-1253(25)00024-X. https://doi.org/10.1016/S2468-1253(25)00024-X.

van Amerongen MJ, Mariappan P, Voglreiter P, Flanagan R, Jenniskens SFM, Pollari M, Kolesnik M, Moche M, Fütterer JJ. Software-based planning of ultrasound and CT-guided percutaneous radiofrequency ablation in hepatic tumors. Int J Comput Assist Radiol Surg. 2021;16(6):1051–7. https://doi.org/10.1007/s11548-021-02394-1.

Article  PubMed  PubMed Central  Google Scholar 

de Baère T, Roux C, Deschamps F, Tselikas L, Guiu B. Evaluation of a new CT-guided robotic system for percutaneous needle insertion for thermal ablation of liver tumors: a prospective pilot study. Cardiovasc Intervent Radiol. 2022;45(11):1701–9. https://doi.org/10.1007/s00270-022-03267-z.

Article  PubMed  PubMed Central  Google Scholar 

Heerink WJ, Ruiter SJS, Pennings JP, Lansdorp B, Vliegenthart R, Oudkerk M, de Jong KP. Robotic versus freehand needle positioning in CT-guided ablation of liver tumors: a randomized controlled trial. Radiology. 2019;290(3):826–32. https://doi.org/10.1148/radiol.2018181698.

Article  PubMed  Google Scholar 

Hendriks P, Boel F, Oosterveer TT, Broersen A, de Geus-Oei LF, Dijkstra J, Burgmans MC. Ablation margin quantification after thermal ablation of malignant liver tumors: How to optimize the procedure? A systematic review of the available evidence. Eur J Radiol Open. 2023;11:100501. https://doi.org/10.1016/j.ejro.2023.100501.

Article  PubMed  PubMed Central  Google Scholar 

Laimer G, Schullian P, Jaschke N, Putzer D, Eberle G, Alzaga A, Odisio B, Bale R. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol. 2020;30(5):2463–72. https://doi.org/10.1007/s00330-019-06609-7.

Article  PubMed  PubMed Central  Google Scholar 

Hendriks P, Noortman WA, Baetens TR, van Erkel AR, van Rijswijk CSP, van der Meer RW, Coenraad MJ, de Geus-Oei LF, Slump CH, Burgmans MC. Quantitative volumetric assessment of ablative margins in hepatocellular carcinoma: predicting local tumor progression using nonrigid registration software. J Oncol. 2019;2019:4049287. https://doi.org/10.1155/2019/4049287.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paolucci I, Albuquerque Marques Silva J, Lin YM, Laimer G, Cignini V, Menchini F, Meira M, Shieh A, O'Connor C, Jones KA, Gazzera C, Fonio P, Brock KK, Calandri M, Menezes M, Bale R, Odisio BC. Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation. Br J Surg. 2024;111(9):znae165. https://doi.org/10.1093/bjs/znae165. Erratum in: Br J Surg. 2024;111(10):znae258.